Novavax, Inc. (NVAX) Reports In-Line Q2 EPS
Tweet Send to a FriendGet Alerts NVAX Hot Sheet
Price: $1.90 -1.55%
Revenue Growth %: -18.1%
Financial Fact:
Net loss: -10M
Today's EPS Names:
ATU, CRWS, CLC, More
Revenue Growth %: -18.1%
Financial Fact:
Net loss: -10M
Today's EPS Names:
ATU, CRWS, CLC, More
Trade NVAX Now!
Novavax, Inc. (NASDAQ: NVAX) reported Q2 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $7.1 million versus the consensus estimate of $6.68 million.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Fedex Corp. (FDX) Tops Q4 EPS by 17c, Sales Light
- Five Below (FIVE) Tops Q1 EPS by 1c, Boosts FY13 Outlook
- Lentuo International (LAS) Swings to Q1 Loss; Updates on Expansion
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
